Concepts (220)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocardial Infarction | 38 | 2022 | 807 | 9.330 |
Why?
|
| Myocardium | 17 | 2021 | 1204 | 3.930 |
Why?
|
| Macrophages | 13 | 2021 | 647 | 2.620 |
Why?
|
| Ventricular Remodeling | 18 | 2022 | 318 | 2.600 |
Why?
|
| Wound Healing | 8 | 2021 | 260 | 2.090 |
Why?
|
| Extracellular Matrix | 10 | 2020 | 493 | 1.940 |
Why?
|
| Heart Failure | 8 | 2021 | 1180 | 1.750 |
Why?
|
| Heart Ventricles | 8 | 2020 | 738 | 1.650 |
Why?
|
| Proteomics | 7 | 2019 | 246 | 1.580 |
Why?
|
| Fibroblasts | 6 | 2020 | 902 | 1.550 |
Why?
|
| Matrix Metalloproteinase 9 | 9 | 2019 | 160 | 1.510 |
Why?
|
| Inflammation | 11 | 2021 | 1030 | 1.510 |
Why?
|
| Periodontitis | 2 | 2021 | 47 | 1.340 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2020 | 11 | 1.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2021 | 266 | 1.250 |
Why?
|
| Porphyromonas gingivalis | 2 | 2021 | 33 | 1.240 |
Why?
|
| Lipopolysaccharides | 3 | 2021 | 455 | 1.210 |
Why?
|
| Neutrophils | 5 | 2020 | 204 | 1.150 |
Why?
|
| Fibrosis | 6 | 2021 | 371 | 1.130 |
Why?
|
| Animals | 39 | 2022 | 20881 | 1.020 |
Why?
|
| Proteome | 3 | 2022 | 87 | 0.890 |
Why?
|
| Extracellular Matrix Proteins | 5 | 2020 | 144 | 0.870 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 940 | 0.820 |
Why?
|
| Heart | 4 | 2021 | 850 | 0.800 |
Why?
|
| Immunity, Innate | 2 | 2019 | 156 | 0.790 |
Why?
|
| Immunologic Memory | 1 | 2021 | 75 | 0.770 |
Why?
|
| Databases, Factual | 3 | 2018 | 622 | 0.760 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 133 | 0.760 |
Why?
|
| Immunity | 1 | 2020 | 67 | 0.720 |
Why?
|
| Endomyocardial Fibrosis | 1 | 2020 | 5 | 0.720 |
Why?
|
| Ventricular Function, Left | 5 | 2020 | 481 | 0.710 |
Why?
|
| Signal Transduction | 8 | 2020 | 2689 | 0.710 |
Why?
|
| Mice, Inbred C57BL | 17 | 2022 | 2791 | 0.690 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 397 | 0.690 |
Why?
|
| Electrocardiography | 1 | 2022 | 601 | 0.690 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 37 | 0.680 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 597 | 0.680 |
Why?
|
| Heart Diseases | 2 | 2022 | 276 | 0.680 |
Why?
|
| Mice | 18 | 2022 | 8474 | 0.660 |
Why?
|
| Liver X Receptors | 1 | 2018 | 8 | 0.640 |
Why?
|
| Retinoid X Receptors | 1 | 2018 | 26 | 0.640 |
Why?
|
| Matrix Metalloproteinases | 2 | 2017 | 223 | 0.620 |
Why?
|
| Iron Overload | 1 | 2018 | 28 | 0.610 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2018 | 15 | 0.610 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2017 | 4 | 0.600 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2018 | 106 | 0.600 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2018 | 47 | 0.590 |
Why?
|
| Phagocytosis | 4 | 2021 | 65 | 0.580 |
Why?
|
| Humans | 31 | 2022 | 68618 | 0.550 |
Why?
|
| Disease Models, Animal | 10 | 2021 | 2550 | 0.530 |
Why?
|
| Receptors, Mitogen | 1 | 2016 | 23 | 0.530 |
Why?
|
| Male | 28 | 2022 | 37321 | 0.520 |
Why?
|
| Vinculin | 1 | 2015 | 15 | 0.520 |
Why?
|
| Software | 1 | 2018 | 418 | 0.510 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 100 | 0.510 |
Why?
|
| Cytoskeleton | 1 | 2015 | 84 | 0.500 |
Why?
|
| Inflammation Mediators | 5 | 2021 | 244 | 0.500 |
Why?
|
| Angiotensin II | 1 | 2016 | 220 | 0.490 |
Why?
|
| Hypertension | 2 | 2020 | 1535 | 0.460 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 383 | 0.450 |
Why?
|
| NF-kappa B | 1 | 2016 | 432 | 0.450 |
Why?
|
| Female | 18 | 2022 | 38074 | 0.430 |
Why?
|
| Biomarkers | 7 | 2020 | 1593 | 0.430 |
Why?
|
| Aging | 2 | 2015 | 911 | 0.410 |
Why?
|
| Myocytes, Cardiac | 3 | 2021 | 442 | 0.390 |
Why?
|
| Phenotype | 5 | 2021 | 947 | 0.380 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1293 | 0.380 |
Why?
|
| Collagen | 4 | 2019 | 636 | 0.370 |
Why?
|
| Cytokines | 7 | 2022 | 866 | 0.360 |
Why?
|
| Neoplasms | 1 | 2020 | 1667 | 0.330 |
Why?
|
| Homeostasis | 2 | 2020 | 291 | 0.310 |
Why?
|
| Leukocytes | 2 | 2020 | 99 | 0.310 |
Why?
|
| CD36 Antigens | 2 | 2019 | 9 | 0.300 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2020 | 155 | 0.290 |
Why?
|
| Organoids | 2 | 2022 | 42 | 0.250 |
Why?
|
| Age Factors | 2 | 2020 | 1864 | 0.240 |
Why?
|
| Prognosis | 2 | 2020 | 2093 | 0.230 |
Why?
|
| Glycoproteins | 2 | 2015 | 238 | 0.220 |
Why?
|
| Cells, Cultured | 4 | 2021 | 2673 | 0.220 |
Why?
|
| Interleukin-4 | 2 | 2020 | 69 | 0.210 |
Why?
|
| Transcriptome | 2 | 2021 | 164 | 0.210 |
Why?
|
| Lymphokines | 2 | 2020 | 49 | 0.210 |
Why?
|
| Mice, Mutant Strains | 2 | 2019 | 166 | 0.200 |
Why?
|
| Myocardial Reperfusion | 1 | 2021 | 32 | 0.190 |
Why?
|
| ROC Curve | 1 | 2022 | 392 | 0.190 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2021 | 84 | 0.190 |
Why?
|
| Neovascularization, Physiologic | 2 | 2019 | 164 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 277 | 0.180 |
Why?
|
| Mast Cells | 1 | 2020 | 113 | 0.180 |
Why?
|
| Valsartan | 1 | 2020 | 99 | 0.180 |
Why?
|
| Cell Transdifferentiation | 1 | 2019 | 12 | 0.180 |
Why?
|
| Myocardial Ischemia | 1 | 2021 | 172 | 0.180 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 57 | 0.170 |
Why?
|
| Chromosomes | 1 | 2019 | 17 | 0.170 |
Why?
|
| Stromal Cells | 1 | 2020 | 113 | 0.170 |
Why?
|
| Cell Communication | 1 | 2020 | 116 | 0.170 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2019 | 7 | 0.170 |
Why?
|
| Natriuretic Peptides | 1 | 2019 | 12 | 0.170 |
Why?
|
| Aminobutyrates | 1 | 2020 | 94 | 0.170 |
Why?
|
| CD8 Antigens | 1 | 2019 | 25 | 0.170 |
Why?
|
| Tetrazoles | 1 | 2020 | 160 | 0.170 |
Why?
|
| Antigens, CD | 1 | 2020 | 230 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2019 | 39 | 0.170 |
Why?
|
| Platelet Factor 4 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Chemokine CXCL6 | 1 | 2018 | 1 | 0.160 |
Why?
|
| Macrophages, Peritoneal | 1 | 2019 | 67 | 0.160 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2018 | 3 | 0.160 |
Why?
|
| Chemokines, CC | 1 | 2018 | 18 | 0.160 |
Why?
|
| Sialoglycoproteins | 1 | 2018 | 24 | 0.160 |
Why?
|
| Sex Factors | 2 | 2021 | 1266 | 0.160 |
Why?
|
| Cell Plasticity | 1 | 2018 | 2 | 0.160 |
Why?
|
| Myofibroblasts | 1 | 2019 | 60 | 0.160 |
Why?
|
| Gene Expression | 3 | 2016 | 770 | 0.150 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 1753 | 0.150 |
Why?
|
| Biomedical Research | 1 | 2021 | 310 | 0.150 |
Why?
|
| Systems Biology | 1 | 2017 | 25 | 0.150 |
Why?
|
| Transforming Growth Factor beta | 1 | 2020 | 384 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2020 | 307 | 0.150 |
Why?
|
| Sex Characteristics | 1 | 2019 | 295 | 0.150 |
Why?
|
| Matrix Metalloproteinase Inhibitors | 1 | 2017 | 59 | 0.140 |
Why?
|
| Mitochondria | 2 | 2019 | 643 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2022 | 2077 | 0.140 |
Why?
|
| Ventricular Dysfunction | 1 | 2016 | 15 | 0.140 |
Why?
|
| Coronary Occlusion | 1 | 2016 | 12 | 0.140 |
Why?
|
| Interleukin-10 | 1 | 2017 | 144 | 0.140 |
Why?
|
| Cardiomyopathies | 1 | 2018 | 167 | 0.140 |
Why?
|
| Placebos | 1 | 2016 | 195 | 0.130 |
Why?
|
| Discoidin Domain Receptors | 1 | 2016 | 16 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2015 | 1692 | 0.130 |
Why?
|
| Losartan | 1 | 2016 | 45 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2018 | 193 | 0.130 |
Why?
|
| Time Factors | 2 | 2021 | 4655 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2016 | 134 | 0.130 |
Why?
|
| Proteolysis | 1 | 2015 | 97 | 0.130 |
Why?
|
| Lung | 1 | 2020 | 849 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 119 | 0.120 |
Why?
|
| Collagen Type I | 1 | 2015 | 175 | 0.120 |
Why?
|
| Bacteroidaceae Infections | 1 | 2014 | 15 | 0.120 |
Why?
|
| Kidney | 1 | 2019 | 945 | 0.120 |
Why?
|
| Citrate (si)-Synthase | 1 | 2014 | 11 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2014 | 121 | 0.120 |
Why?
|
| Blood Pressure | 1 | 2020 | 1451 | 0.120 |
Why?
|
| Mutation | 1 | 2019 | 1213 | 0.120 |
Why?
|
| Periodontal Diseases | 1 | 2014 | 54 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2016 | 313 | 0.110 |
Why?
|
| Cell Polarity | 3 | 2020 | 49 | 0.110 |
Why?
|
| Aged | 3 | 2018 | 14862 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2014 | 525 | 0.110 |
Why?
|
| Chronic Disease | 1 | 2017 | 1330 | 0.110 |
Why?
|
| Sepsis | 1 | 2015 | 233 | 0.100 |
Why?
|
| Apoptosis | 2 | 2016 | 1641 | 0.100 |
Why?
|
| Cell Movement | 1 | 2014 | 630 | 0.100 |
Why?
|
| Middle Aged | 3 | 2018 | 21147 | 0.100 |
Why?
|
| Risk Factors | 1 | 2019 | 5731 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1174 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 4848 | 0.080 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.070 |
Why?
|
| Models, Biological | 2 | 2022 | 981 | 0.070 |
Why?
|
| Cicatrix | 2 | 2017 | 60 | 0.070 |
Why?
|
| United States | 1 | 2018 | 7367 | 0.070 |
Why?
|
| Ligation | 2 | 2016 | 83 | 0.070 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 209 | 0.060 |
Why?
|
| Adult | 2 | 2021 | 21403 | 0.060 |
Why?
|
| Reperfusion | 1 | 2021 | 78 | 0.050 |
Why?
|
| Species Specificity | 1 | 2021 | 303 | 0.050 |
Why?
|
| Consensus | 1 | 2021 | 211 | 0.050 |
Why?
|
| Rats, Inbred Dahl | 1 | 2020 | 48 | 0.050 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2020 | 45 | 0.040 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2020 | 50 | 0.040 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2021 | 86 | 0.040 |
Why?
|
| Diastole | 1 | 2020 | 161 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 2019 | 24 | 0.040 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 184 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2020 | 304 | 0.040 |
Why?
|
| ADAMTS Proteins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Infusions, Subcutaneous | 1 | 2019 | 5 | 0.040 |
Why?
|
| Integrin beta4 | 1 | 2019 | 2 | 0.040 |
Why?
|
| Sodium | 1 | 2019 | 161 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 1038 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 140 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2020 | 586 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2018 | 489 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1033 | 0.040 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 35 | 0.040 |
Why?
|
| Energy Metabolism | 1 | 2018 | 222 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2016 | 254 | 0.030 |
Why?
|
| Genotype | 1 | 2018 | 786 | 0.030 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2016 | 85 | 0.030 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 145 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 498 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 266 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 163 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2015 | 45 | 0.030 |
Why?
|
| Cardiac Volume | 1 | 2015 | 21 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 137 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2016 | 791 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2016 | 241 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 710 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2015 | 308 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 282 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 442 | 0.030 |
Why?
|
| Glycosylation | 1 | 2014 | 185 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2018 | 1174 | 0.030 |
Why?
|
| Pepsin A | 1 | 2013 | 8 | 0.030 |
Why?
|
| Alkylation | 1 | 2013 | 26 | 0.030 |
Why?
|
| Buffers | 1 | 2013 | 31 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1083 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2013 | 43 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2013 | 24 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 714 | 0.030 |
Why?
|
| Solubility | 1 | 2013 | 134 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 1447 | 0.030 |
Why?
|
| Binding Sites | 1 | 2014 | 631 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1034 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 284 | 0.030 |
Why?
|
| Echocardiography | 1 | 2015 | 515 | 0.030 |
Why?
|
| Rats | 1 | 2020 | 5300 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 1465 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 567 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2022 | 7277 | 0.020 |
Why?
|
Deleon-pennell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(220)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_